Mosaic ImmunoEngineering Inc. (CPMV) shareholders
Close on Oct 19, 2026Market cap $2.41MP/E –Yield –
Ownership
Institutional holdings as of Sep 30, 2025, from 13F filings
Shares held by institutions
Top institutional holders
13F holdings as of Sep 30, 2025
| Holder | Shares | % of CPMV | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| West Oak Capital, LLC | 1 | 0.00% | $0 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q3 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2025 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2024 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2024 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2024 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2024 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2023 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2023 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2023 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2023 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2022 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Robert L. Garnick Director | Jan 29, 2021 | Conversion | +356,794 | – | – | 356,794 |
| Steven W. King President and CEO, Director, 10% owner | Jan 29, 2021 | Conversion | +1,641,252 | – | – | 1,641,252 |
| Paul J. Lytle EVP, Chief Financial Officer, Director, 10% owner | Jan 29, 2021 | Conversion | +1,641,252 | – | – | 1,641,252 |
| Nicole Franziska Steinmetz Acting CSO, Director, 10% owner | Jan 29, 2021 | Conversion | +570,870 | – | – | 570,870 |
| Nicole Franziska Steinmetz Acting CSO, Director, 10% owner | Jan 29, 2021 | Conversion | +1,641,252 | – | – | 1,641,252 |
| Clifford L. Flowers CFO and Interim CEO | Apr 17, 2013 | Option exercise | +75,000 | $0.10 | $7.50K | 75,000 |
| Gloria Felcyn Director | Apr 30, 2012 | Award | +48,200 | $0.10 | $4.82K | 951,690 |
| Gloria Felcyn Director | Apr 27, 2012 | Award | +4,500 | $0.10 | $450 | 903,490 |
| Gloria Felcyn Director | Apr 26, 2012 | Award | +89,290 | $0.10 | $8.93K | 898,990 |
| Helmut Falk Jr Director | Dec 9, 2009 | Option exercise | +100,000 | $0.07 | $7.00K | 2,622,731 |
| Helmut Falk Jr Director | Oct 27, 2009 | Sale | −25,000 | $0.30 | $7.50K | 2,522,731 |
| Paul R. Bibeau VP, Business Development | Apr 15, 2009 | Buy | +100,000 | $0.10 | $10.00K | 400,000 |
| Paul R. Bibeau VP, Business Development | Jan 30, 2009 | Buy | +98,000 | $0.12 | $11.76K | 298,000 |
| Paul R. Bibeau VP, Business Development | Jan 30, 2009 | Buy | +2,000 | $0.11 | $220 | 300,000 |
| Carlton M. Johnson Director | Nov 26, 2008 | Buy | +46,800 | $0.12 | $5.62K | 431,800 |
| Carlton M. Johnson Director | Nov 26, 2008 | Buy | +30,000 | $0.11 | $3.30K | 461,800 |
| Carlton M. Johnson Director | Nov 26, 2008 | Buy | +63,200 | $0.11 | $6.95K | 525,000 |
| Carlton M. Johnson Director | Nov 25, 2008 | Buy | +10,000 | $0.11 | $1.10K | 385,000 |
| Helmut Falk Jr Director | Nov 21, 2008 | Buy | +100,000 | $0.11 | $11.00K | 200,000 |
| Frederick C. Goerner Chief Executive Officer | Nov 21, 2008 | Buy | +80,000 | $0.12 | $9.60K | 400,000 |
| Frederick C. Goerner Chief Executive Officer | Nov 21, 2008 | Buy | +20,000 | $0.11 | $2.20K | 320,000 |
| Paul R. Bibeau VP, Business Development | Nov 21, 2008 | Buy | +62,780 | $0.11 | $6.91K | 122,780 |
| Paul R. Bibeau VP, Business Development | Nov 21, 2008 | Buy | +10,000 | $0.11 | $1.10K | 60,000 |
| Paul R. Bibeau VP, Business Development | Nov 21, 2008 | Buy | +15,500 | $0.11 | $1.71K | 138,280 |
| Paul R. Bibeau VP, Business Development | Nov 21, 2008 | Buy | +61,720 | $0.12 | $7.41K | 200,000 |
| Frederick C. Goerner Chief Executive Officer | Nov 20, 2008 | Buy | +189,000 | $0.12 | $22.68K | 300,000 |
| Frederick C. Goerner Chief Executive Officer | Nov 20, 2008 | Buy | +111,000 | $0.11 | $12.21K | 111,111 |
| Harry L. Tredennick Director | Nov 20, 2008 | Buy | +115,959 | $0.11 | $12.76K | 115,959 |
| Harry L. Tredennick Director | Nov 20, 2008 | Buy | +64,041 | $0.11 | $7.04K | 180,000 |
| Carlton M. Johnson Director | Nov 20, 2008 | Buy | +100,000 | $0.11 | $11.00K | 375,000 |
| Gloria Felcyn Director | Nov 20, 2008 | Buy | +36,520 | $0.11 | $4.02K | 658,870 |
| Gloria Felcyn Director | Nov 20, 2008 | Buy | +163,480 | $0.12 | $19.62K | 822,350 |
| Gloria Felcyn Director | Nov 20, 2008 | Buy | +5,000 | $0.11 | $550 | 827,350 |
| Gloria Felcyn Director | Nov 20, 2008 | Buy | +75,000 | $0.11 | $8.25K | 622,350 |
| Helmut Falk Jr Director | Oct 21, 2008 | Option exercise | +100,000 | $0.05 | $5.00K | 2,543,231 |
| Helmut Falk Jr Director | Jun 30, 2008 | Buy | +50,000 | $0.19 | $9.50K | 2,603,231 |
| Helmut Falk Jr Director | Jun 30, 2008 | Buy | +50,000 | $0.20 | $10.00K | 2,553,231 |
| Paul R. Bibeau VP, Business Development | Apr 24, 2008 | Buy | +50,000 | $0.37 | $18.50K | 50,000 |
| Frederick C. Goerner Chief Executive Officer | Apr 15, 2008 | Buy | +190,000 | $0.33 | $62.70K | 290,000 |
| Frederick C. Goerner Chief Executive Officer | Apr 15, 2008 | Buy | +10,000 | $0.32 | $3.20K | 300,000 |
| Gloria Felcyn Director | Apr 15, 2008 | Buy | +10,000 | $0.31 | $3.10K | 499,700 |
| Gloria Felcyn Director | Apr 15, 2008 | Buy | +5,000 | $0.32 | $1.60K | 504,700 |
| Gloria Felcyn Director | Apr 15, 2008 | Buy | +25,000 | $0.32 | $8.00K | 529,700 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +5,000 | $0.39 | $1.95K | 65,000 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +7,500 | $0.39 | $2.93K | 35,000 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +10,000 | $0.39 | $3.90K | 45,000 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +5,000 | $0.38 | $1.90K | 22,500 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +7,500 | $0.38 | $2.85K | 17,500 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +10,000 | $0.38 | $3.80K | 10,000 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +2,500 | $0.39 | $975 | 100,000 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +25,000 | $0.39 | $9.75K | 97,500 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +7,500 | $0.39 | $2.93K | 72,500 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +5,000 | $0.38 | $1.90K | 27,500 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +7,500 | $0.39 | $2.93K | 60,000 |
| Frederick C. Goerner Chief Executive Officer | Mar 4, 2008 | Buy | +7,500 | $0.39 | $2.93K | 52,500 |
| Gloria Felcyn Director | Sep 14, 2007 | Option exercise | +100,000 | $0.10 | $10.00K | 489,700 |
| David Pohl Director | Aug 28, 2007 | Tax withholding | −173,404 | $0.47 | $81.50K | 1,882,846 |
| David Pohl Director | Aug 28, 2007 | Option exercise | +500,000 | $0.16 | $80.00K | 2,056,250 |
| Helmut Falk Jr Director | Aug 7, 2007 | Option exercise | +25,000 | $0.07 | $1.75K | 2,503,231 |
| David Pohl Director | Aug 6, 2007 | Option exercise | +1,000,000 | $0.17 | $170.00K | 1,900,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Mosaic ImmunoEngineering's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?